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Genetic mutations in a6b4 integrin cause junctional
epidermolysis bullosa with pyloric atresia, a genoder-
matosis characterized by blistering of the skin and
pyloric occlusion. The lethal form of junctional
epidermolysis bullosa with pyloric atresia has been
mainly associated with the presence of premature ter-
mination codons in the mRNA encoding either the a6
or b4 subunit causing rapid decay of the mutated tran-
script and absence of a6b4 integrin. In this study, we
disclose the genetic background of lethal junctional
epidermolysis bullosa with pyloric atresia in a patient
presenting absent expression of a6 integrin despite nor-
mal steady-state level of the a6b4 mRNA. Screening for
mutation in the a6 gene detected a homozygous base
pair substitution (286 C-to-T), which results in the sub-
stitution of a serine with a leucine residue (S47L). The
amino acid substitution S47L localizes in the ¢rst b-
strand of the seven-bladed b-propeller structure of the
extracellular head of a6 integrin, and triggers a rapid
proteolysis of the aberrant polypeptides involving the
lysosomal degradation pathway. This study provides
new insight into the pathogenic e¡ect of a mis-sense
mutation a¡ecting a functional domain of a protein,
and identi¢es a critical peptide sequence of the b-pro-
peller domain conserved among the a integrin cell re-
ceptors. Key words: integrin a6b4/lysosome/proteasome/skin
blistering disease/b-propeller. J Invest Dermatol 121:1336 ^
1343, 2003
I
ntegrins constitute a superfamily of heterodimeric cell ad-
hesion receptors composed of a a and b subunit linked by
noncovalent bonds. Integrins mediate cell^cell and cell^
matrix interactions and modulate a variety of functions, in-
cluding cell growth, di¡erentiation, and apoptosis (Hynes,
1992). Each cell displays a speci¢c repertoire of integrins that in-
teract with multiple ligands and de¢ne the adhesion properties.
Integrin a6 is expressed in a variety of tissues, but in epithelia it
exclusively interacts with b4 integrin to form the a6b4 heterodi-
mer, which is polarized at the ventral side of the basal cells and
mediates interactions with the adhesion ligand laminin-5 and
other laminin isoforms (Lee et al, 1992; Niessen et al, 1994). In all
integrins, the interchain interactions between the a and b subu-
nits are mediated by the NH2-terminal b-propeller domain of
the a polypeptide that contains seven conserved repeats folded
in a speci¢c conformation (Huang and Springer, 1997; Lu et al,
1998). The b-propeller domain of a6 integrin directly interacts
with the I/A domain of the b4 subunit and plays a crucial part
in the ligand binding properties of the a6b4 heterodimer
(Kamata et al, 2001).
Integrin a6 is synthesized as a 140 kDa precursor that is con-
verted into two disul¢de-linked polypeptides of 120 and 25 kDa
by endoproteolytic cleavage of the C-terminal domain (Hemler
et al, 1989). This post-translational cleavage of the a6 precursor oc-
curs at a site rich in basic amino acids and involves the serine en-
doprotease furin (Lehmann et al, 1996). The endoproteolytic
processing takes place downstream of the endoplasmic reticulum
(ER), probably in the trans-Golgi network (Rigot et al, 1999).
The precursor a6 chain associates with its b4 partner in the ER
under the control of chaperone proteins. Calnexin, an ER-resi-
dent molecular chaperone has been involved in addressing, fold-
ing, and assembly of a6b1 integrin in endothelial cells (Lenter
and Vestweber, 1994) and a6b4 integrin in adenocarcinoma cells
(Rigot et al, 1999). Evidence has been provided that calnexin tran-
siently binds with the individual integrin a6 and b4 chains with-
in the ER, mediates the correct folding of the newly synthesized
polypeptides, and assists their assembly into a6b4 heterodimers. It
has been shown that calnexin remains bound to misfolded or un-
assembled polypeptides, which are thus retained in the ER before
addressing to the proteolytic pathways (Okazaki et al, 2000).
Genetic mutations in the gene (ITGA6) for a6 integrin cause
junctional epidermolysis bullosa associated with pyloric occlusion
(PA-JEB) a variant of recessively inherited blistering disorders
(JEB) that manifest shortly after birth (Vidal et al, 1995; Ruzzi
et al, 1997). PA-JEB is characterized by detachments and erosions
of the squamous and transitional epithelia with the cleavage plane
Manuscript received March 20, 2003; revised May 5, 2003; accepted for
publication May 20, 2003
1Present address: Gilles Lestringant, Consultant Dermatologist, British
Forces in Germany Health Service, BFPO 39 (Germany).
wEqually contributed to this work.
Address correspondence and reprint requests to: Guerrino Meneguzzi,
INSERM U385, U.F.R. de MeŁ decine, Avenue de Valombrose, 06107 Nice
Cedex 2, France. Email: meneguzz@unice.fr
Abbreviations: PA-JEB, junctional epidermolysis bullosa with pyloric
atresia; MoAb, monoclonal antibody; PoAb, polyclonal antibody; ER,
endoplasmic reticulum.
0022-202X/03/$15.00 . Copyrightr 2003 by The Society for Investigative Dermatology, Inc.
1336
of the blisters lying within the lamina lucida of the epidermal
basement membrane (Fine, 2000).Widespread blistering and ero-
sions of the integument and oral mucosa with involvement of the
gastrointestinal, genitourinary, and respiratory epithelia are hall-
marks of PA-JEB. Loss of skin (aplasia cutis congenita) is a feature
currently observed in severe PA-JEB (Lestringant et al, 1992). This
lethal form results mostly from genetic mutations that obliterate
expression of a6b4 integrin, whereas the mild manifestation of
the condition, which is compatible with life, correlates with mu-
tations allowing expression of abnormal but still functional a6b4
integrin molecules. Involvement of a6b4 integrin in the etio-
pathology of PA-JEB has disclosed the crucial role of this integrin
in the assembly of hemidesmosomes, the stable adhesion struc-
tures adjoining the basal cells of strati¢ed and transitional epithe-
lia to the mesenchyme (Borradori and Sonnenberg, 1999). The
interaction of the cytoplasmic domain of b4 integrin with plectin
initiates the recruitment of the hemidesmosome components and
this intermolecular association is essential for the stability of the
hemidesmosomal structure (Schaapveld et al, 1998; Koster et al,
2001). Accordingly, a6- and b4-null PA-JEB patients and knock-
out mice present a reduced number of malformed, and therefore
inoperative, hemidesmosomes (Dowling et al, 1996; Georges-La-
bouesse et al, 1996; van der Neut et al, 1996). So far the lethal form
of PA-JEB has been reported to be caused by genetic mutations
occurring mostly in the b4 subunit but also in several cases with-
in the a6 polypeptide. The majority of these mutations create
premature termination codon in the a6 or b4 integrin transcripts,
thus triggering instability of the mutated transcripts and so ab-
sent expression of a6b4 integrin.
In this study we report for the ¢rst time that a mis-sense muta-
tion (S47L) in the b-propeller domain of a6 integrin is associated
with a severe form of PA-JEB.We demonstrate that the S47L mis-
sense mutation triggers the rapid and massive proteolytic degrada-
tion of the mutated a6 polypeptide. Our results thus disclose the
strict control exerted by the post-translational machinery of the
cell on the ligand binding domain of the integrin cell receptors.
MATERIALS AND METHODS
Clinical features The proband was a newborn male from a con-
sanguineous union of una¡ected Emirate Arabian parents. Diagnosis of
PA-JEB was established on the basis of clinical observations. At birth, the
patient presented aplasia cutis congenita and microtia. Aplasia involved the
legs, feet, nose, the right jaw, and both pinnae (Fig 1). Blistering of the skin
and mucosa consequent to friction occurred shortly after birth. PA was
detected at radiology, and a pyloric ablation was performed at the age of 4
d. At day 10 of age, aspiration pneumonia, consequent to nasojejunal
feeding, caused deterioration of the general conditions. Widespread skin
and oral mucosa blistering concomitant with thrombocytopenia and
neutropenia resulted in septicemia and death 26 d after birth.
Ultrastructural examination of PA-JEB skin biopsies revealed that the
cleft plane of the blisters localized within the lamina lucida of the
dermal^epidermal junction (not shown).
Immunohistochemistry Immunohistochemical studies were perfor-
med on 4 mm thick sections from skin biopsies (Verrando et al, 1991).
Immuno£uorescence of cultured keratinocytes was performed on cell
cultures grown for 36 h on glass coverslips, ¢xed using the aqueous
mounting medium Gel/Mount (Biomeda, Foster City, California) and
then treated as described (Gache et al, 1996). Tissue sections and cell
cultures were analyzed under an epi£uorescence Zeiss Axiophot
microscope.
Cell cultures Epidermis from skin biopsies was dissociated in 0.25%
trypsin^ethylenediamine tetraacetic acid at 371C and plated on a feeder of
irradiated mouse 3T3-J2 cells (Rheinwald and Green, 1975). Keratinocytes
were grown in a 3:1 mixture of Dulbecco minimal Eagle’s medium/Ham’s
F12 medium (Gibco BRL, Life Technologies, Cergy Pontoise, France)
supplemented with serum (Hyclone, Perbio Sciences, Bezons, France) and
growth factors (Rheinwald and Green, 1975). HaCaT and epithelial 293
cells were grown in Dulbecco minimal Eagle’s medium containing 10%
calf serum (Gibco BRL, Life Technologies). Subcon£uent keratinocyte
cultures were transfected using 3 mg of plasmid DNA and the polyca-
tionic lipid Fugene (Stratagene, Amsterdam, the Netherlands), as detailed
elsewhere (Gagnoux-Palacios et al, 2001). Epithelial 293 cells were
transfected using 3 mg of DNA and the calcium-phosphate technique
(Chen and Okayama, 1987).
Antibodies The antibodies used were: anti-b4 integrin monoclonal
antibody (MoAb) 439^9B (Kennel et al, 1990), MoAb 3E1 (Gibco BRL,
Life Technologies), and polyclonal antibody (PoAb) anti-b4 integrin
(Niessen et al, 1994); anti-a6 integrin MoAb GoH3 (Sonnenberg et al,
1987), MoAb 1A10 (Hogervorst et al, 1993a), MoAb 4E9G8 (Immunotech,
Marseille, France), MoAb SC-6597 (Santa-Cruz, Tebu, Le Perray en
Yvelines, France); the anti-plectin HD121 (Hieda et al, 1992) and the anti-
a3 integrin MoAb VM2 (Novocastra Laboratories, Tebu). Secondary
antibodies were £uorescein isothiocyanate-conjugated goat anti-mouse
immunoglobulin (Dako S.A., Trappes, France) and Texas red-conjugated
goat anti-mouse immunoglobulin (Dako S.A.).
Plasmids Plasmids pa6WT and pb4WT are derived from vector pRC-
CMV (Invitrogen, Life Technologies, Cergy Pontoise, France) and contain
the full-length a6 and b4 integrin cDNA, respectively (Hogervorst et al,
1993b; Niessen et al, 1994). Plasmid pa6M, encoding the mutated S47L a6
integrin, was gene-rated by polymerase chain reaction (PCR) ampli¢cation
using the QuickChange site-directed mutagenesis kit (Stratagene), primers
(left) 50 -AGCCTCTTCGGCTTCTTGCTGGCCATGCAC-30 and (right)
50 -G CCAGTGCATGGCCAGCAAGAAGCCGAAGA-30 and plasmid
pa6WT as a template. Plasmid pGFP encoding the Green Fluorescent
Protein was purchased from Invitrogen, Life Technologies.
Immunoprecipitation and western blot analysis Exponentially
growing keratinocytes were maintained for 24 h in methionine- and
cysteine-de¢cient culture medium (Gibco BRL, Life Technologies)
supplemented with 110 mCi per mL 35S-methionine and 35S-cysteine, 3%
Figure1. Clinical features of the newborn with PA-JEB. Extensive
blistering and erosions of the integument are the hallmarks of the condi-
tion. Note the malformation of the external ears and areas with absence of
epithelium.
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fetal calf serum (Invitrogen, Life Technologies), and 2 mM glutamine
(Invitrogen, Life Technologies). Samples of the cell lysates (107 cpm) were
cleared using rabbit anti-mouse IgG (Sigma, St Louis, Missouri)
conjugated to protein A-Sepharose (Amersham Pharmacia Biotech, Orsay,
France), and then processed as previously described (Gagnoux-Palacios et al,
1996). For western analysis, 48 h after transfection, 293 cells were treated
with either 50 or 150 mM chloroquine (Sigma), 0.5 or 20 mM MG132
(Calbiochem, Meudon, France), or with 10 mM lactacystin (Calbiochem)
during 6 h. PA-JEB keratinocytes were treated for 24 h with either 5 or
10 mM lactacystin or either 50 or 150 mM chloroquine. Cells were lyzed
using 0.5% sodium deoxycholate, 1% nonidet P-40, and 20 mM Tris^
HCl pH 6.8, in the presence of proteases inhibitors (Gagnoux-Palacios
et al, 1996). The cell extracts were fractionated in sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE) under reducing con-
ditions. Immunoblotting was performed according to standard procedure
and the hybridization bands were visualized using the ECL detection system
(Amersham Pharmacia Biotech).
Northern analysis Total RNAwas puri¢ed from cultured keratinocytes
using the RNable extraction kit (Eurobio, Les Ullis, France) and 10 mg
were fractionated in a denaturing 1% agarose-formaldehyde gel
(Chavanas et al, 1996). 32P-labeled random-primed cDNA probes phb4
(Hogervorst et al, 1990), pha6 (Hogervorst et al, 1991), and GAPDH were
used to detect the a6, b4 integrin, and GAPDH RNA transcripts,
respectively.
Screening for genetic mutations Twenty micrograms of total RNA
puri¢ed from the PA-JEB keratinocytes were reverse transcribed in a
volume of 50 mL using avian myeloblastosis virus reverse transcriptase
(Promega, Charbonnie' res, France). One microliter of the reaction mixture
was used to amplify overlapping 500 bp cDNA fragments spanning the
open reading frame of integrins b4 (5.6 kb) and a6 (6.1 kb) RNA
transcripts. The ampli¢ed cDNA fragments were directly sequenced using
an ABI Prism 310 automated sequencing system (Applied Biosystems,
Foster City, California). Genomic DNA was puri¢ed from peripheral
blood following standard techniques and used (100 ng) as a template for
PCR ampli¢cation and direct sequencing.
In vitro translation One microgram of plasmid DNA was incubated
with 40 mL of the coupled Transcription/Translation TnT Quick Mater
Mix Systems (Promega) and 20 mCi of 35S methionine (Amersham
Pharmacia Biotech) for 90 min at 301C. Two microliters of the incubation
mixture were analyzed by 7.5% SDS^PAGE.The translation products were
visualized by autoradiography of the polyacrylamide gel.
RESULTS
Expression of the a6 and b4 integrin in the proband’s
keratinocytes Frozen sections from the proband’s skin in
nonlesional epidermis were performed using antibodies reacting
to the major basement membrane components. Staining of the
epidermal basement membrane with MoAb GoH3 directed
against a6 integrin was negative, and was strongly reduced with
MoAb 439-9B speci¢c to the b4 integrin subunit (Fig 2Aa,c).
Staining of the dermal^epidermal junction was also negative
with MoAb 135-13C speci¢c to the N-terminal region of a6
integrin (not shown). In contrast, MoAb HD121 to plectin
reacted with the dermal^epidermal junction and the staining
pattern was comparable with that noted in healthy controls (Fig
2Ae). A similar continuous staining of the dermal^epidermal
junction was obtained with antibodies speci¢c to the other
hemidesmosome components, the 230 kDa bullous pemphigoid
antigen-1 (BPAG1) and collagen type XVII (data not shown).
Strong reactivity was also observed with antibodies speci¢c to
the basement membrane components, including laminin-5 and
types IV and VII collagens (data not shown). In contrast, labeling
with the anti-a3 integrin antibody MoAb VM2 revealed
relocalization of a3b1 integrin at the dermal^epidermal junction
(Fig 2Ag). Relocalization of a3 integrin was previously observed
in other JEB patients, and is thought to compensate absence of
a6b4 integrin in cell adhesion (Niessen et al, 1996; Gagnoux-
Palacios et al, 1997; Ruzzi et al, 1997). These observations
indicated that a6 or b4 integrin were the candidate genes for
PA-JEB in this proband.
To con¢rm that loss of immunoreactivity to a6b4 integrin
correlated with an altered expression of this cellular receptor,
immunoprecipitation analysis was performed on cell extracts
obtained from the proband’s keratinocytes. MoAb GoH3
immunoprecipitated the a6b4 integrin complex from wild-type
human keratinocytes, but not from the proband’s cells (Fig 2B).
Consistent with this result, MoAb 3E1, speci¢c to the b4 integrin
subunit, immunoprecipitated the heterodimer a6b4 from the
control cells, but only the b4 integrin subunit from the PA-JEB
keratinocytes (Fig 2B). Altogether, these results and the
Figure 2. Expression of a6b4 integrin in the proband’s keratino-
cytes. (A) Immuno£uorescence analysis of noninvolved skin of the PA-
JEB patient (a,c,e,g) and a healthy control (b,d,f,h) treated with MoAb
GoH3 to a6 integrin (a,b), MoAb 439-9B to b4 integrin (c,d), MoAb
HD121 to plectin (e,f) and MoAbVM2 to a3 integrin (g,h). Compared with
the control, the patient’s skin was not reactive to MoAb GoH3 and was
weakly stained by MoAb 439-9B. Immunostaining with HD121 is com-
parable in the patient’s and the control’s skin. In the proband, labeling with
VM2 is relocalized at the ventral side of the basal keratinocytes. Arrows
point out the dermal^epidermal junction. (B) Immunoprecipitation analy-
sis of keratinocytes extracts obtained from cultures of wild-type (C) and
PA-JEB keratinocytes (P) using MoAb GoH3 to a6 integrin and MoAb
3E1 to b4 integrin. Expression of b4 integrin is detected in the patient’s
keratinocytes, whereas a6 integrin is absent. The apparent molecular mass
markers are indicated on the left (kDa).
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immuno£uorescence studies suggest that in this patient a6
integrin is not expressed, and expression of b4 integrin is
drastically reduced. Decreased expression of the integrin partner
of a mutated integrin chain has been reported both in PA-JEB
patients and mice with null mutations in either a6 or b4
subunits (Vidal et al, 1995; Dowling et al, 1996; Georges-
Labouesse et al, 1996; van der Neut et al, 1996; Ruzzi et al, 1997).
Identi¢cation of mutation S47L in the a6 cDNA In a
pathologic context, absence of a mutated polypeptide is usually
caused by enhanced decay of the corresponding aberrant
mRNA consequent to the presence of a premature termination
codon generated by a genetic mutation. To assess this possibility,
we analyzed the expression level of the RNA transcripts
encoding the a6b4 integrin in the proband’s keratinocytes.
Total RNA isolated from primary cultures of the proband’s
keratinocytes was analyzed by northern blot using a 32P-labeled
cDNA probes speci¢c to the integrin a6 and b4 subunits. The
steady-state level of a6 or b4 subunit mRNA in the PA-JEB
keratinocytes was found to be comparable with that of the
control wild-type keratinocytes (Fig 3A). We therefore
concluded that absence of the a6 integrin in the patient’s
keratinocytes is not associated with a transcriptional defect or
enhanced decay of a6 mRNA.
To verify whether absence of the a6 integrin polypeptide in
the patient’s skin is associated with the presence of a genetic
mutation in the gene ITGA6, total RNA puri¢ed from cultured
keratinocytes of the proband was ampli¢ed by reverse
transcription^PCR. Direct sequencing of the ampli¢ed PCR
products detected a homozygous base pair substitution that
changes the cytosine at position 286 into a thymidine (286
C-to-T) (Fig 3B). Direct sequencing of exon 1 of gene ITGA6
ampli¢ed by PCR using genomic DNA of the proband and the
proband’s parents as templates demonstrated homozygosity of the
patient for the mutation 286 C-to-T and heterozygosity of
the healthy parents (Fig 3B). The Mendelian inheritance of the
mutation was assessed by genotyping of the di¡erent members
of the PA-JEB family (Fig 3C). Variation 286 C-to-T was not
detected in alleles in a cohort of 100 healthy unrelated
individuals (data not shown). This base pair transition substitutes
the codon for serine 47 with a codon for a leucine residue (S47L)
and results in a mis-sense mutation localized within a stretch of
four amino acids highly conserved in a integrins (Fig 4).
Speci¢cally, the S47L mutation localizes within the ¢rst anti-
parallel b-strand of the ¢rst repeat of the b-propeller of a6
integrin (Fig 3D). No additional nucleotide sequence variation
was detected in the coding sequence of a6 integrin (not shown).
Mutation S47L hampers expression of a6 integrin To
demonstrate the causative role of the mis-sense S47L mutation
in the absence of a6 integrin expression, we cotransfected the
proband’s keratinocytes using a eukaryotic vector express-
ing either the full-length wild-type a6 cDNA (pa6WT) or a
mutated counterpart carrying transition 286 C-to-T (pa6M)
with the GFP expression vector pGFP. Analysis of the
transfected keratinocytes by immuno£uorescence staining using
MoAb GoH3 revealed lack of expression of the mutated
recombinant a6 integrin and e⁄cient expression of the wild-
type a6 polypeptide (Fig 5Ab,c). The keratinocytes expressing
the wild-type a6 integrin also restored expression of b4
integrin, which conversely, was not detected in the PA-JEB
keratinocytes transfected with the mutant a6 cDNA (Fig 5Bb,c).
These results demonstrate the negative e¡ect of the S47L
mutation on expression of a6b4 integrin.
To assess whether lack of expression of the mutant a6 integrin
was due to accelerated degradation of the aberrant neo-
synthesized polypeptide or to a reduced translation rate of the
mutant a6 RNA messenger, vectors pa6M and pa6WT were
used as templates for an in vitro translation assay in the presence
of radioactive 35S-labeled methionine. Analysis of the translated
polypeptides by 7.5% SDS^PAGE showed that both the wild-
type and the mutated cDNA templates allow synthesis of a
comparable amount of a6 polypeptide exhibiting the apparent
molecular mass (140 kDa) of the precursor a6 integrin (Fig 5C).
We then concluded that the mis-sense S47L mutation does not
interfere with translation of the abnormal a6 mRNA, but rather
a¡ects the stability of the mutated polypeptide.
Mutation S47L causes high instability of a6 integrin
polypeptide To verify the idea that the S47L mutation triggers
instability of the neo-synthesized a6 integrin in vivo, we followed
Figure 3. (A) Northern analysis of total RNA puri¢ed from control
(C) and PA-JEB keratinocytes (P) using 32P-labeled cDNA probes
speci¢c to a6 integrin, b4 integrin, and GAPDH. In the control and
patient’s keratinocytes the steady-state level of the a6 and b4 mRNA tran-
scripts is comparable. (B) Identi¢cation of the sequence variation 286 C-to-
T. Direct nucleotide sequencing of the PCR ampli¢ed fragments of exon 1
of the ITAG6 gene detected a C-to-T transition at position 286 homozy-
gous in the proband (P) and heterozygous in the proband’s parents. Father
(F), unrelated control (C). (C) Pedigree of the nuclear PA-JEB family. Arab
numbers identify the 10 family members genotyped in this study. The pro-
band (¢lled symbol), carriers of the S47L mutation (half ¢lled symbols)
and wild-type members (empty symbols) are indicated. (D) Schematic re-
presentation of the b-propeller domain of a integrins. Position of the S47L
mutation in the ¢rst b-strand of repeat 1 (W1) is indicated (star).
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the fate of the mutated a6 integrin using an overexpressing
eukaryotic system. Epithelial 293 cells were cotransfected with
vector pb4WT expressing the wild-type b4 integrin and either
plasmid pa6M or plasmid pa6WT. Forty-eight hours after
transfection, western blot analysis of the cellular extracts obta-
ined from the transfected cells and separated on a 7.5% SDS^
PAGE was performed using MoAb 4E9G8 directed against the
COOH-terminal domain of a6 integrin that detects the
Figure 4. Nucleotide sequence homology of the 50 cDNA sequence in integrin a chains. Alignment of human integrins a6, a3, a2b,
a5, and a4 sequences for the ¢rst N-terminal repeat of the b-propeller was made using the ClustalWalignment software (Thompson et al, 1994).
Conserved amino acids are framed in black, semiconserved amino acids are boxed in gray and the nonconserved amino acids are indicated by
light boxes. Assignment of the ¢rst b-strand within the ¢rst repeat in integrin a4 (underlined) is according to Springer (1997).
GenBank accession numbers: NP000201 (a6 integrin); NP002195 (a3 integrin); A34269 (a2b integrin); P08648 (a5 integrin); P13612 (a4 integrin).
Figure 5. (A,B) Immuno£uorescence
analysis of the proband’s keratinocytes
cotransfected with expression vector
pGFP encoding the GFP reporter
gene, and either vector pa6WT ex-
pressing the wild-type a6 integrin or
vector pa6M expressing the mutant
S47L a6. (A) PA-JEB keratinocytes un-
transfected (a), cotransfected with vectors
pGFP and pa6WT (b) or pGFP and
pa6M (c) were stained with MoAb GoH3
to a6 integrin. Transfection with vector
pa6WT results in expression of a6 integ-
rin, whereas transfection of pa6M fails to
express a6 polypeptides. (B) PA-JEB kera-
tinocytes untransfected (a) or transfected
with vector pGFP either alone (d) or with
vectors pa6WT (b,e) and pa6M (c,f ) were
stained with the anti-integrin b4 MoAb
3E1 (a^c). Among the transfected PA-JEB
cells expressing GFP (d^f ), only keratino-
cytes transfected with vector pa6WT ex-
pressed b4 integrin (b), whereas those
transfected with pa6M did not react with
MoAb 3E1 (c). (C) In vitro translation assay.
Plasmids pa6WT, pa6M, and pb4WT
were used as templates in a coupled tran-
scription/translation system in the presence
of radioactive 35S methionine. Analysis of
the translated polypeptides by 7.5% SDS^
PAGE shows synthesis of comparable
amounts of wild-type and mutant S47L
a6 polypeptides. Negative control is assay
with no DNA central (C). The apparent
molecular mass markers are indicated on
the left (kDa).
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proteolytically uncleaved a6 precursor and the light chain of the
proteolytically cleaved a6 integrin (Fig 6A). In 293 cells
expressing plasmid pa6WT, a strong hybridization signal was
observed at the apparent molecular mass of 25 kDa, which
corresponds to the migration position of the a6 light chain. A
signal corresponding to the migration mass (140 kDa) of the a6
chain precursor was also detectable (Fig 6A, lane 7). In contrast,
in 293 cells expressing the mutant S47L a6 integrin, only a faint
hybridization double band with an apparent mass slightly inferior
to the a6 integrin precursor was detected (Fig 6A, lane 10). These
results con¢rm that the presence of the mis-sense S47L mutation
dramatically reduces the expression level of a6 integrin. To assess
whether the decreased expression level of the mutated S47L a6
integrin correlates with instability of the neo-synthesized a6
polypeptide, the transfected 293 cells were exposed to increasing
concentrations of chloroquine, an inhibitor of the lysosomal
proteolytic pathway. In the presence of both 50 and 150 mM
chloroquine, 293 cell cultures transfected with plasmid pa6WT
expressed amounts of a6 integrin comparable with those found
in untreated 293 cells (Fig 6A, lanes 8 and 9). The proteolytic
cleavage of the a6 integrin precursor appeared to be a¡ected,
however, as judged from the intensity of the 140 and 25 kDa
hybridization bands in treated and untreated cells. The 293 cells
transfected with plasmid pa6M expressed reduced amounts of
the mutant S47L a6 integrin, and only the precursor form was
detectable. The expression level of the mutated a6 polypeptide
was increased in the presence of chloroquine (Fig 6A, lanes 11
and 12) compared with the untreated counterpart (Fig 6A, lane
10). Western blot analysis of 293 cells transfected with vector
pb4WT using an anti-b4 integrin PoAb showed that chloro-
quine had no appreciable e¡ect on the expression level of b4
integrin (Fig 6A, lanes 4^12). The hybridization signal was more
intense in the presence of wild-type a6 integrin, however, due to
b4 integrin interaction with a6 integrin and formation of stable
a6b4 heterodimers (Fig 6A, lanes 7^9). Altogether, these results
indicate that the S47L mutation triggers instability of a6 integrin,
which is at least partially mediated by the lysosomal degradation
pathway.
To assess whether proteasomal proteolysis could also be
implicated in the degradation of the mutated S47L a6 integrin,
the transfected 293 cells were treated with MG132 or lactacystin,
two speci¢c inhibitors of the proteasomal degradation pathway.
Western blot analysis of transfected cells treated with these
drugs failed to demonstrate the implication of the proteasomal
degradation pathway in the degradation of the mutant S47L a6
integrin (data not shown).
Because the chloroquine treatment increased the stability of
the mutated a6 integrin in 293 cells, we wanted to verify this
observation in PA-JEB keratinocytes. Cell extracts of PA-JEB
keratinocytes grown in the presence of chloroquine were
analyzed by 10% SDS^PAGE and immunoblotting using PoAb
SC-6597, speci¢c to the N-terminal domains of a6 integrin.
Extract from untreated PA-JEB keratinocytes showed a unique
weak signal corresponding to the 140 kDa unprocessed a6
integrin (Fig 6B, lane 1). A stronger hybridization signal with an
identical electrophoretic mobility was detected in extracts of the
proband’s keratinocytes treated with chloroquine (Fig 6B, lanes 4
and 5). These ¢ndings con¢rmed the inhibitory action of
chloroquine on degradation of the mutant a6 polypeptide.
Treatment with lactacystin failed to stabilize the mutant a6
integrin in the PA-JEB cell cultures (Fig 6B, lanes 2 and 3).
Altogether, these results demonstrate that the mutant S47L a6
integrin is detected at extremely low levels in the proband’s
keratinocytes as an unstable precursor a6 polypeptide rapidly
degraded by the cell.
DISCUSSION
The widespread disadhesion of the strati¢ed epithelia and PA
characteristic of lethal PA-JEB have so far been associated with
absent expression of a6b4 integrin consequent to genetic muta-
tions that generate premature termination codons mainly in the
b4 but also for a minor part in the a6 integrin messenger RNA
(Vidal et al, 1995; Ruzzi et al, 1997). Premature termination codons
are known to cause rapid decay of the mutated RNA transcripts
and reduction of their steady-state levels (McIntosh et al, 1993). In
this study, we examined the genetic background of a severe form
of PA-JEB associated with lack of skin immunoreactivity to a6
integrin antibodies despite synthesis of stable a6 integrin mole-
cules at levels comparable with those detected in healthy controls.
Screening for genetic mutations associated the PA-JEB phenotype
with a homozygous point mutation in exon 1 of the gene ITGA6
resulting in the substitution of a serine residue with a leucine
(S47L) in a6 integrin. Lines of evidence suggested the causative
role of the mis-sense S47L mutation in PA-JEB: (1) besides transi-
tion 286 C-to-T in the proband’s genomic DNA that leads to
substitution S47L, no additional sequence variation was detected
in the cDNA for a6 integrin and the regulatory DNA sequences
of the ITGA6 gene compared with wild-type controls; (2) the
mutated ITGA6 allele was exclusively found in a heterozygous
state in healthy carriers of the proband’s family, and was not de-
tected in cohorts of unrelated healthy individuals; (3) transition
286 C-to-T a¡ected neither expression nor stability of the mu-
tated integrin a6 messenger RNA; (4) transfer of the a6 cDNA
carrying transition 286 C-to-T into integrin a6-null PA-JEB ker-
Figure 6. Western analysis of epithelial cell cultures expressing the
mutant S47L a6 integrin after treatment with protease inhibitors.
(A) Untransfected (NT) 293 epithelial cells (lanes 1^3), transfected with
vector pb4WT (lanes 4^6), or cotransfected with vectors pb4WT and
pa6WT (lanes 7^9), or vectors pb4WTand pa6M (lanes 10^12) were treated
with 50 mM (lanes 2, 5, 8, 11) or 150 mM (lanes 3, 6, 9, 12) chloroquine. Un-
treated cells: lanes 1, 4, 7, 10. Cells extracts (40 mg) were analyzed by 7.5%
SDS^PAGE and immunoblotting using MoAb 4E9G8 speci¢c to a6 integ-
rin C-terminal domain or PoAb anti-b4 integrin. The migration bands
identifying the a6 precursor (140 kDa), the a6 light chain polypeptide (25
kDa) and b4 integrin (200 kDa) are indicated. The molecular weight mar-
kers are reported on the left (kDa). (B) PA-JEB keratinocytes were treated
for 24 h with 10 mM (lane 2) or 5 mM (lane 3) lactacystin, or with 150 mM
(lane 4) or 50 mM (lane 5) chloroquine. Untreated PA-JEB keratinocytes
(lane 1) and HaCaT cells (C). Cell extracts (100 mg) were analyzed in 10%
SDS^PAGE andWestern blot analysis was done using MoAb SC-6597 to
the NH2-terminus of a6 integrin. The migration bands identifying the a6
precursor (140 kDa) and the a6 heavy chain polypeptide (120 kDa) are
indicated.
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atinocytes failed to restore detectable expression of a6 integrin;
and (5) the S47L a6 integrin failed to be normally expressed in
293 cells.
The deleterious e¡ect of mis-sense mutations on functionality
and/or stability of proteins is a well-known cause of genetic dis-
orders (Bross et al, 1999; Soto, 2001). The aberrant proteins are re-
tained in the cell cytoplasm and degraded. It has been previously
reported that mis-sense mutations in the extracellular domain of
b4 integrin may be responsible for a few cases of lethal PA-JEB
(Pulkkinen et al, 1998; Nakano et al, 2001). In this study, we report
one of the ¢rst cases of lethal PA-JEB caused by a mis-sense mu-
tation in the a6 integrin and for the ¢rst time we explain the
molecular mechanisms underlying the pathogenesis of the pa-
tient. Indeed, in this PA-JEB patient the polypeptide is virtually
undetectable by immunohistochemistry and immunoblot ana-
lyses, both in the patient’s keratinocytes in vivo and in a6-null
keratinocytes in vitro after transient transfection with the mutant
a6 cDNA. Nevertheless, the extremely rapid degradation rate of
the aberrant a6 polypeptide by the cell machinery was inferred
from the fact that the mutated integrin was expressed in in vitro
translation assays at levels comparable with those obtained with a
wild-type control, and that its presence was detected by western
blot analysis in extracts of 293 cells transfected with a mutated
S47L a6 cDNA and used as an eukaryotic overexpression system.
The rapid degradation of the mutant a6 is intriguing, because
several functional studies on integrin a chains have been per-
formed by directed mutagenesis of the N-terminal domains of
the polypeptides, and, to our knowledge, instability of the mu-
tant recombinant integrin a chains has never been observed. For
instance, mutagenesis of the a4 subunit residues Gly130 and
Gly190 conserved in all the a integrin b-propeller domains has
been shown to induce conformational changes that a¡ect associa-
tion of a4 integrin with the integrin b1 subunit and binding to
ligands without altering the stability of the mutated a4 chain
(Guerrero-Esteo et al, 1998). In this study, the rapid decay of the
abnormal a6 polypeptide may be explained by the particular lo-
calization of the S47L mutation, within a stretch of four amino
acids (FGFS), which is part of the ¢rst b-strand of the ¢rst ami-
no-terminal repeat of the seven that form the seven-bladed
b-propeller structure of the extracellular head of integrin a units
(Springer, 1997). The achievement of the crystal structure of the
integrin aVb3 extracellular portion has con¢rmed that the toroi-
dal arrangement of the seven amino-terminal b-sheets mediates
the interaction of a subunits with the b subunits partners and
regulates binding of the integrin heterodimers with their extra-
cellular ligands (Xiong et al, 2001). The b-propeller, which is
found in numerous proteins, was ¢rst identi¢ed in the b subunits
of heterotrimeric guanosine triphosphate-binding proteins (G
proteins), where it mediates the a/b subunit interactions (Sondek
et al, 1996). The correct conformation of the b-propeller structure
is therefore expected to undergo strict control by the post-trans-
lational machinery of the cell. This hypothesis is con¢rmed by
mis-sense mutations a¡ecting the b4 subunit. As a general rule,
mis-sense mutations within b4 integrin are associated with the
nonlethal form of PA-JEB. For a few exceptions, however,
mis-sense mutations may cause a lethal phenotype. In these cases,
mis-sense mutations a¡ect conserved amino acids of the putative
b4 integrin ligand binding domain (Nakano et al, 2001).
Diverse diseases, including epidermolysis bullosa, arise from
protein misfolding (Soto, 2001). Aberrantly folded neo-synthe-
sized polypeptides stably interact with molecular chaperones that
drive proteolytic degradation by intracellular proteases. For in-
stance, calnexin was shown to retain mutated a1-anti-trypsin in
the ER before degradation of the abnormal protein by the pro-
teasome, with consequent a1-anti-trypsin de¢ciency and onset of
pathologies, such as infantile liver disease and adult emphysema
(Qu et al, 1996; Liu et al, 1997). Protein degradation also takes place
in the lysosome after protein re-orientation from the trans-Golgi
network (Ellgaard et al, 1999). From our studies based on the use
of proteasome-speci¢c inhibitors, we could not demonstrate the
implication of this protein degradation pathway in the removal of
the mutated a6 polypeptide, because in our experimental condi-
tions treatments with the proteasome inhibitors MG132 and
lactacystin a¡ect expression of the wild-type a6 integrin.
Conversely, the involvement of the lysosomal pathway in degra-
dation of the mutated a6 integrin was suggested by the positive
e¡ect exerted by chloroquine on the stability of the aberrant
polypeptide. Considering, however, that the treatment by chlor-
oquine does not fully preserve expression of the mutated a6 in-
tegrin, and also that degradation of the aberrant polypeptide is
extremely rapid, the implication of di¡erent protein degradation
pathways is likely. Treatment of the transfected 293 cells with
chloroquine and the proteasome inhibitors also show that most
of the mutated a6 polypeptide precursor displays an enhanced
electrophoretic mobility, which possibly re£ects an altered post-
translational modi¢cation. Interestingly, our results also indicate
that chloroquine interferes with the proteolytic maturation of
the wild-type 140 kDa a6 integrin precursor by furin, which is
in agreement with previous observations reporting that chloro-
quine hinders the movement of furin along the endocytic path-
way by neutralizing endosomal acidi¢cation (Chapman and
Munro, 1994).
In conclusion, our results demonstrate that mutation S47L in-
duces a rapid degradation of the neo-synthesized a6 polypeptide
because substitution of the polar serine with the hydrophobic
leucine residue alters folding in a key functional domain of the
integrin a chains. The extremely accelerated decay of the mutated
a6 polypeptide resulting in absent expression of a6b4 integrin
underlies the severity of the condition. Our studies also provide
new insight into the pathogenic e¡ect of mis-sense mutations and
into functional domains of the integrin cell receptors.
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